Does TOFACITINIB Cause Dyspnoea? 5,312 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 5,312 reports of Dyspnoea have been filed in association with TOFACITINIB (XELJANZ XR). This represents 3.4% of all adverse event reports for TOFACITINIB.
5,312
Reports of Dyspnoea with TOFACITINIB
3.4%
of all TOFACITINIB reports
1,049
Deaths
2,124
Hospitalizations
How Dangerous Is Dyspnoea From TOFACITINIB?
Of the 5,312 reports, 1,049 (19.7%) resulted in death, 2,124 (40.0%) required hospitalization, and 1,183 (22.3%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 5,312 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which TOFACITINIB Alternatives Have Lower Dyspnoea Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN